We are pleased to invite investors and analysts to participate in our virtual event on Monday, 16 May 2022, presenting Roche’s access to healthcare strategy highlighting initiatives from both the Diagnostics and Pharmaceuticals divisions. 15:00 – 16:30 CEST / 14:00 - 15:30 BST 09:00 – 10:30 am EDT / 6:00 – 7:30 am PDT The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:00 CEST on the day of the event. > click here Agenda Welcome Bruno Eschli, Head of Investor Relations Roche Sustainability Strategy Pascale Schmidt, Chief Compliance and Sustainability Officer How Roche Diagnostics enables access to healthcare Thomas Schinecker, CEO Roche Diagnostics Driving Access to Diagnostics across the Globe  Stefan Seliger, Head Global Access & Policy, Diagnostics Division Driving Access to Medicine across the Globe Michael Oberreiter, Head Global Access, Pharmaceuticals Division Q&A Access to virtual event (pre-registration required) Please pre-register for our webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com. A replay of the webcast will be available via > ir.roche.com *privacy notice Best regards,

Bruno Eschli  Head of Investor Relations

 

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

  

get the latest news and updates to your inbox.